Russia Considers Ban on E-cigarette Additives: Industry Voices Concerns

Aug.09.2023
Russia Considers Ban on E-cigarette Additives: Industry Voices Concerns
Russia's Health Ministry is set to introduce a bill prohibiting certain additives in e-cigarettes, including nicotine salts and flavorings.

In a press conference, Artyom Metchelyov, Chairman of the Youth Policy Committee of the State Duma of Russia, announced that the Russian Ministry of Health will soon submit a bill to the Russian Cabinet for review, which aims to ban the use of additives in e-cigarettes.


This list of substances banned from increasing the appeal of nicotine-containing liquids includes:


Food additives, herbal flavoring agents, and their derivatives, including vanillin, cocoa and its derivatives, licorice, spices, and any natural flavorings are prohibited. Synthetic sugars and synthetic or natural sweeteners are also prohibited. Additionally, additives that enhance nicotine addiction, such as nicotine salts, ethanol, ammonium, and ammonia, are banned.


According to a report from the Russian newspaper "News Report" on August 8th, the Russian Union of Nicotine-Containing Product Industry (Союз предприятий индустрии никотиносодержащих изделий, abbreviated as СПИНИ) and the Professional Alliance of Participants in the Russian Market of Electronic Nicotine Systems (Профессиональный альянс участников русского рынка электронных никотиновых систем, abbreviated as ПАУРРЭНС) have sent a letter to Russian Finance Minister Anton Siluanov, requesting the removal of food flavorings and salt-based nicotine from the list of banned substances and additives.


This letter has received support from over 50 industry professionals and experts in the e-cigarette sector. Among them is Lev Grigoriev, Chairman of BABYLON, a leading e-cigarette compliant distributor in Russia, who also opposes the policy change.


Lev Grigoriev stated:


Flavorings are used in all e-cigarette liquids, many of which are not noticeable. Many flavorings are processed using technology and without them, the product would be unusable. In other words, it is illogical to completely ban all flavorings as there is no similar situation in the world.


The Ministry of Health recommends exclusively using liquid products containing propylene glycol and glycerol, much like suggesting a complete ban on all types of alcohol such as wine, liquor, brandy, and so on, and only utilizing pure ethanol.


The second recommendation concerns nicotine salts. What are nicotine salts? From a chemical standpoint, they are simply nicotine. So why does the Ministry of Health believe they can be addictive? Addiction is not caused by nicotine itself, but rather by its concentration.


The recommendation from the Ministry of Health is unlikely to solve the problem it claims to address - reducing the accessibility of nicotine products for minors and teenagers. Examples of similar bans include snus, a tobacco product in Sweden. Although snus is still available on the market, it is supplied illegally without the payment of taxes. This significantly impacts consumers who may be exposed to low-quality and unsafe products. Similarly, if the use of nicotine salts and flavorings is prohibited, the situation would likely be comparable.


What are the recommendations from industry experts regarding the market? It is not to completely ban all flavors, as e-cigarettes are composed of various substances.


Taking into account that minors make up approximately 11.2% of all e-cigarette consumers, we are actively striving to restrict accessibility to underage individuals. However, under the current circumstances, this measure would affect around 90% of adult users.


References:


[1] The business sector has requested not to ban the use of flavorings in vaping products. [2] Vape sellers are requesting not to ban flavorings.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Philip Morris Korea launched TEREA Limona Pearl in South Korea on August 31, 2026, expanding the TEREA Fresh Blend capsule tobacco stick lineup from four variants to five. Designed for the IQOS ILUMA series, the new stick combines a capsule with what the company calls a Fresh Filter. Philip Morris Korea describes the product as offering an aromatic, refreshing flavor profile with a cooling sensation, with an additional fresh note released when the capsule is crushed. The recommended retail price is KRW 4,800 per pack, with sales through IQOS stores and convenience stores nationwide. No reliable evidence has been found that the same Limona Pearl SKU was previously officially launched in another major IQOS market.
Sep.01
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market
Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market
According to SGST on August 26, 2026, Australia’s Coalition Illegal Tobacco Taskforce released a report recommending an up to 80% cut in tobacco excise to reduce the appeal of the illicit tobacco market. The report claimed organised crime groups now control about 80% of Australia’s tobacco market and argued that high excise rates have widened the price gap between legal and illegal products. The recommendation remains a policy proposal and has not been adopted by the Australian government, which said its focus remains on enforcement, compliance and additional resources.
Aug.27
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03